Advertisement
Canada markets open in 2 hours 24 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7295
    -0.0006 (-0.09%)
     
  • CRUDE OIL

    81.70
    -0.20 (-0.24%)
     
  • Bitcoin CAD

    90,718.55
    +121.73 (+0.13%)
     
  • CMC Crypto 200

    1,424.15
    +9.39 (+0.66%)
     
  • GOLD FUTURES

    2,319.60
    -26.80 (-1.14%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,412.50
    +62.50 (+0.36%)
     
  • VOLATILITY

    16.60
    -0.34 (-2.01%)
     
  • FTSE

    8,072.56
    +48.69 (+0.61%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6843
    -0.0007 (-0.10%)
     

Cannabis firm Tilray posts bigger quarterly loss as investments weigh

FILE PHOTO: Cannabis plants grow inside the Tilray factory in Cantanhede

(Reuters) - Canadian pot producer Tilray Inc <TLRY.O> reported a bigger quarterly loss on Tuesday, as it ramped up investments to boost production in an attempt to grab a larger share of the nascent cannabis market and expand internationally.

The company's cost of sales, or the cost related to pot production and its supply, rose more than six-fold to $33.6 million in the second quarter from a year earlier.

Shares of the company were down 2% after the closing bell.

The results came on the back of increasing demand in the Canadian cannabis sector, which has faced supply constraints.

Canada became the first G7 country to legalize recreational marijuana in October but sales have been dampened by supply constraints and prices that are higher than those on the black market.

ADVERTISEMENT

The larger players such as Canopy Growth <WEED.TO> and Aurora Cannabis <ACB.N>, and Tilray have spent heavily to bridge the supply-demand gap, often resulting in bigger losses, spooking investors waiting for any sign of profitability.

Tilray said total kilogram equivalents of cannabis sold in the second quarter surged nearly 270% to 5,588 kg, while average selling price per gram fell to $4.61 from $6.38 a year earlier.

The company's net loss widened to $35.1 million, or 36 cents per share, in the quarter ended June 30, from $12.8 million, or 17 cents per share, a year earlier.

Excluding items, the company posted a loss of 32 cents per share, it said.

Analysts on average had expected a loss of 25 cents, according to IBES data from Refinitiv.

Revenue rose to $45.9 million from $9.7 million, beating the average analyst estimate of $41.1 million.

(Reporting by Debroop Roy in Bengaluru; Editing by Maju Samuel)